Literature DB >> 34958046

Effects of Cannabis in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Berzenn Urbi1,2, Joel Corbett3, Ian Hughes1, Maame Amma Owusu1, Sarah Thorning1, Simon A Broadley2,3, Arman Sabet2,3, Saman Heshmat2,4.   

Abstract

The legalization of cannabis in many countries has allowed many Parkinson's disease (PD) patients to turn to cannabis as a treatment. As such there is a growing interest from the PD community to be properly guided by evidence regarding potential treatment benefits of cannabis. This systematic review and meta-analysis aims to compile the best available evidence to help guide patients and their family, clinicians and researchers make informed decisions. A systematic search of the literature was conducted in June 2021. Five randomized controlled studies and eighteen non-randomized studies investigated cannabis treatment in PD patients. No compelling evidence was found to recommend the use of cannabis in PD patients. However, a potential benefit was identified with respect to alleviation of PD related tremor, anxiety, pain, improvement of sleep quality and quality of life. Given the relative paucity of well-designed randomized studies, there is an identified need for further investigation, particularly in these areas.

Entities:  

Keywords:  Cannabis; Parkinson’s disease; UPDRS; efficacy of cannabis; tremor

Mesh:

Substances:

Year:  2022        PMID: 34958046     DOI: 10.3233/JPD-212923

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  3 in total

Review 1.  Overcoming the impact of physiologic tremors in ophthalmology.

Authors:  Gurfarmaan Singh; Wilson Wong Jun Jie; Michelle Tian Sun; Robert Casson; Dinesh Selva; WengOnn Chan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-07-05       Impact factor: 3.117

Review 2.  Randomized controlled trials on the use of cannabis-based medicines in movement disorders: a systematic review.

Authors:  P Oikonomou; W H Jost
Journal:  J Neural Transm (Vienna)       Date:  2022-07-20       Impact factor: 3.850

Review 3.  Parkinson's disease, dopaminergic drugs and the plant world.

Authors:  Peter Kempster; Andrew Ma
Journal:  Front Pharmacol       Date:  2022-09-05       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.